![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Bayliss K M, Kueck B D, Johnson S T, Fueger J T, McFadden P W, Mikulski D, et al. Detecting fetomaternal hemorrhage: a comparison of five methods. Transfusion 1991; 31: 303–307
- Bowman J M. Controversies in Rh prophylaxis: who needs Rh immune globulin and when should it be given?. American Journal of Obstetrics and Gynecology 1985; 151: 289–294
- Cardwell M S. Fetomaternal hemorrhage: when to suspect, how to manage. Postgraduate Medicine 1987; 82: 127–130
- Cohen F, Zueler W, Gustafson D C, Evans M M. Mechanisms of isoimmunisation – The transplacental passage of fetal erythrocytes in homospecific pregnancies. Blood 1964; 23: 621–646
- Devi B, Jennison R F, Langley F A. Relationship of transplacental hemorrhage to abnormal pregnancy and delivery. Journal of Obstetrics and Gynaecology of British Commonwealth 1968; 75: 659–666
- Elliot J P. Massive fetomaternal hemorrhage treated by fetal intravascular transfusion. Obstetrics and Gynecology 1991; 78: 520–523
- Emery C L, Morway L F, Chung-Park M, Wyatt-Ashmead J, Sawady J, Beddow T D. The Kleihauer – Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use. Archives of Pathological Laboratory Medicine 1995; 119: 1032–1037
- Giacoia G P. Severe fetomaternal hemorrhage: a review. Obstetrical and Gynecological Survey 1997; 52: 372–380
- Kleihauer E, Braun H, Betke K. Demonstration von fetalem hemoglobin in der erythrocyten eines blutausstrichs. Klinische Wochenschrift 1957; 35: 637–638
- Laube D W, Schauberger C W. Fetomaternal bleeding as a cause for ‘unexplained’ fetal death. Obstetrics and Gynecology 1982; 60: 649–651
- Letsky E A, de Silva M. Preventing Rh Immunisation. British Medical Journal 1994; 309: 213–214
- Li T C, Bromham D R, Balmer B M. Fetomaternal macrotransfusion in the Yorkshire region – Prevalence and obstetric factors. British Journal of Obstetrics and Gynaecology 1988; 95: 1144–1151
- Lubenko A, Collier R, Williams M, Hindmarch D, Wilson S, Pluck J. Quantitating fetomaternal hemorrhages of D+ red cells using an FITC-conjugated IgG monoclonal anti-D by flow cytometry: a case report. Immunohematology 1997; 13: 1214
- Mollison P L. Quantification of transplacental haemorrhage. British Medical Journal 1972; 3: 31–34
- Ness P M, Baldwin M L, Niebyl J R. Clinical high-risk designation does not predict excess fetal-maternal hemorrhage. American Journal of Obstetrics and Gynecology 1987; 156: 154–158
- Pelikan D M, Scherjon S A, Mesker W E, de Groot-Swings G M, Brouwer-Mandema G G, Tanke H J, et al. Quantification of fetomaternal hemorrhage: a comparative study of the manual and automated microscopic Kleihauer-Betke tests and flow cytometry in clinical samples. American Journal of Obstetrics and Gynecology 2004; 191: 551–557
- Salim R, Ben-Shlomo, Nachum Z, Mader R, Shalev E. The incidence of large fetomaternal hemorrhage and the Kleihauer – Betke test. Obstetrics and Gynecology 2005; 105: 1039–1044
- Sebring E S, Polesky H F. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990; 30: 344–357
- Stedman C M, Baudin J C, White C A, Cooper E S. Use of the erythrocyte rosette test to screen for excessive fetomaternal in Rh-negative women. American Journal of Obstetrics and Gynecology 1986; 154: 1363–1369